ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

March 15, 1985

Also Senate approves spending bill.

January 23, 2004

In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants

June 24, 1983

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001

NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’

May 17, 1991